SRCL - Stericycle Inc Stock Price Quote - NASDAQ | Morningstar

Skip to Content

Is it the right time to buy or sell?

Find out with Morningstar Investor

Is it the right time to buy or sell?

Find out with Morningstar Investor

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

We Continue to See a Pathway for Stericycle to Improve Profit Margins

Sector Director Brian Bernard

Brian Bernard, CFA, CPA Sector Director

Business Strategy and Outlook

| Brian Bernard, CFA, CPA | May 13, 2022

Since its founding in 1989, Stericycle has been extremely acquisitive, having acquired over 500 companies. On the surface, this acquisitive strategy led to a lengthy period of impressive growth and the firm built unmatched scale. However, acquisitions began to stray from Stericycle's core competencies and poor integration efforts caused inefficiencies to build. After decades of strong growth and profitability, Stericycle's financial performance began to deteriorate in 2017.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics - SRCL

Stericycle Inc's Company Profile

Business Description

Stericycle is the largest provider of medical waste disposal and data destruction (primarily paper shredding) services in the United States. Its next closest national competitor in the medical waste disposal space is Sharps Compliance, which generated $76 million of sales in fiscal 2021 (about 4% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business (Shred-It) is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle has a global presence, with about 20% of its revenue earned outside North America.

Contact

2355 Waukegan Road
Bannockburn, IL, 60015

T +1 847 367-5910

StericycleIR@stericycle.com

www.stericycle.com

Sector Industrials

Industry Waste Management

Most Recent Earnings Mar 31, 2022

Fiscal Year End Dec 31, 2022

Stock Type Distressed

Employees 15,000

Stericycle Inc's Related News

33 Undervalued Stocks

Here are our analysts' top ideas in each sector at the third quarter's end.

Susan Dziubinski

Quarter-End Insights

Industrials: Sector Fairly Valued Overall, but Industrial Distributors Look Compelling

Industrials has outperformed despite signs of an economic slowdown and fears over tariffs.

Keith Schoonmaker

Quarter-End Insights

Industrials: Bargains Among Industrial Distributors, Farm & Construction Machinery

The stocks in this sector look fairly valued, and tariffs seem to be only a minor threat.

Keith Schoonmaker

A Simple Yet Well-Executed Approach to Dividend-Paying Stocks

At Silver-rated T. Rowe Price Equity Income, yield, valuation, quality of management, and company fundamentals all matter.

Katie Rushkewicz Reichart

Stock Strategist

Pricing Reset Needles Stericycle's Growth, but Shares Undervalued

Small-quantity rollbacks won't weigh on the stock indefinitely.

A Buying Opportunity for Narrow-Moat Stericycle

The medical-waste management leader is trading at a discount but will face heightened volatility in the year ahead.

13 New Stocks in the Wide Moat Focus Index

The Morningstar Wide Moat Focus Index has added several semiconductor stocks and asset managers, among others, to its roster.

Susan Dziubinski

10 Newest Stocks in the Wide-Moat Focus Index

The Morningstar Wide Moat Focus Index made room for some undervalued consumer defensive stocks in June.

Headwinds for Stericycle but Shares Undervalued

The narrow-moat firm offers attractive upside potential for value investors who can handle volatility.

Stock Analyst Update

Stericycle: Restructuring Weighs, Shares Attractive

Restructuring efforts will yield material longer term benefits, but at today's price, shares offer an attractive margin of safety to patient investors willing to stomach near-term volatility.

What a Thriving Global Economy Means for Stocks

For the first time since the recession, all OECD-tracked countries are growing at the same time. And that presents opportunities.

Bryan Borzykowski

6 New Stocks in the Wide Moat Focus Index

The Morningstar Wide Moat Focus Index adds some healthcare and tech, eschews some financial services stocks.

32 Undervalued Stocks

With 2017 in the books, our equity analysts name their best ideas in every sector.

Quarter-End Insights

Industrials: Pockets of Uncertainty Present a Few Opportunities

Industrials are the second-most-expensive sector we cover, but these picks can reward investors.

Investing Specialists

Morningstar Runs the Numbers

We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended Nov. 17.

Morningstar.com

25 Cheap Stocks

Whether you prefer higher-quality companies or more speculative fare, there's plenty of good ideas on our list.

Stock Strategist

Stericycle Sell-Off Overdone

We think the shares currently offer a significant margin of safety to investors.

Barbara Noverini

The 15 Cheapest Stocks in the Wide Moat Focus Index

These high-quality names are on sale.

Susan Dziubinski

4 Cheap Picks in Our Wide Moat Focus Index

Stericycle, Express Scripts, Allergan, and Disney have strong competitive advantages and are trading at a discount to our fair value estimates.

6 New Stocks in the Wide Moat Focus Index

The Morningstar Wide Moat Focus Index scoops up some asset managers and jettisons some real estate stocks.

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.